Ken Kumagai
Papers
2
Total Citations
28
H-Index
2
About
Ken Kumagai is a leading researcher in urologic oncology and orthopedic infectious disease, whose work bridges surgical innovation and molecular diagnostics. His most impactful contribution addresses a critical quality-of-life concern in prostate cancer treatment: early return of urinary continence following robot-assisted radical prostatectomy (RARP). In his highly cited 2014 paper (25 citations), Kumagai systematically evaluated current techniques to improve continence outcomes, helping to establish RARP as a viable alternative to open surgery in Japan and globally. More recently, Kumagai has advanced the field of periprosthetic joint infection (PJI) diagnosis. His 2024 study introduced a bead-beating assay during synovial fluid DNA extraction, significantly improving real-time PCR accuracy for detecting Gram-positive bacteria—a notoriously difficult diagnostic challenge. This work, already garnering 3 citations shortly after publication, promises to reduce false negatives in PJI detection. By combining surgical expertise with cutting-edge molecular methods, Kumagai demonstrates a rare ability to improve both surgical outcomes and diagnostic precision, making him a valuable contributor to two distinct medical specialties.
Research Focus
Key Achievements
Top Papers
- 1
- 2